Bacterial outer membrane vesicles as a platform for biomedical applications: An update
- PMID: 32333919
- DOI: 10.1016/j.jconrel.2020.04.031
Bacterial outer membrane vesicles as a platform for biomedical applications: An update
Abstract
Outer membrane vesicles (OMVs) are produced by Gram-negative bacteria both in vitro and in vivo. OMVs are nano-sized spherical vehicles formed by lipid bilayer membranes and contain multiple parent bacteria-derived components. Based on the presence of bacterial antigens, pathogen-associated molecular patterns (PAMPs), adhesins, various proteins and the vesicle structure, OMVs have been developed for biomedical applications as bacterial vaccines, adjuvants, cancer immunotherapy agents, drug delivery vehicles, and anti-bacteria adhesion agents. In this review, we analyze the contributions of the structure and composition of OMVs to their applications, summarize the methods used to isolate and characterize OMVs, and highlight recent progress and future perspectives of OMVs in biomedical applications.
Keywords: Adjuvants; Anti-bacteria adhesion agents; Bacterial vaccines; Cancer immunotherapy agents; Drug delivery vehicles; Outer membrane vesicles.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declared that they have no conflicts of interest to this work.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
